Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells

The functional plasticity and anti-tumor potential of human γδ T cells have been widely studied. However, the epigenetic regulation of γδ T-cell/tumor cell interactions has been poorly investigated. In the present study, we show that treatment with the histone deacetylase inhibitor Valproic acid (VP...

Full description

Bibliographic Details
Main Authors: Jaydeep Bhat, Samuel Dubin, Alexandra Dananberg, Elgar Susanne Quabius, Juergen Fritsch, C. Marie Dowds, Ankit Saxena, Guranda Chitadze, Marcus Lettau, Dieter Kabelitz
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.00569/full
_version_ 1828518800765485056
author Jaydeep Bhat
Samuel Dubin
Alexandra Dananberg
Elgar Susanne Quabius
Elgar Susanne Quabius
Juergen Fritsch
C. Marie Dowds
C. Marie Dowds
Ankit Saxena
Guranda Chitadze
Marcus Lettau
Dieter Kabelitz
author_facet Jaydeep Bhat
Samuel Dubin
Alexandra Dananberg
Elgar Susanne Quabius
Elgar Susanne Quabius
Juergen Fritsch
C. Marie Dowds
C. Marie Dowds
Ankit Saxena
Guranda Chitadze
Marcus Lettau
Dieter Kabelitz
author_sort Jaydeep Bhat
collection DOAJ
description The functional plasticity and anti-tumor potential of human γδ T cells have been widely studied. However, the epigenetic regulation of γδ T-cell/tumor cell interactions has been poorly investigated. In the present study, we show that treatment with the histone deacetylase inhibitor Valproic acid (VPA) significantly enhanced the expression and/or release of the NKG2D ligands MICA, MICB and ULBP-2, but not ULBP-1 in the pancreatic carcinoma cell line Panc89 and the prostate carcinoma cell line PC-3. Under in vitro tumor co-culture conditions, the expression of full length and the truncated form of the NKG2D receptor in γδ T cells was significantly downregulated. Furthermore, using a newly established flow cytometry-based method to analyze histone acetylation (H3K9ac) in γδ T cells, we showed constitutive H3K9aclow and inducible H3K9achigh expression in Vδ2 T cells. The detailed analysis of H3K9aclow Vδ2 T cells revealed a significant reversion of TEMRA to TEM phenotype during in vitro co-culture with pancreatic ductal adenocarcinoma cells. Our study uncovers novel mechanisms of how epigenetic modifiers modulate γδ T-cell differentiation during interaction with tumor cells. This information is important when considering combination therapy of VPA with the γδ T-cell-based immunotherapy for the treatment of certain types of cancer.
first_indexed 2024-12-11T19:00:53Z
format Article
id doaj.art-68e6aa2d09404ae286c0bba6866dc74d
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T19:00:53Z
publishDate 2019-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-68e6aa2d09404ae286c0bba6866dc74d2022-12-22T00:54:01ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-03-011010.3389/fimmu.2019.00569440486Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor CellsJaydeep Bhat0Samuel Dubin1Alexandra Dananberg2Elgar Susanne Quabius3Elgar Susanne Quabius4Juergen Fritsch5C. Marie Dowds6C. Marie Dowds7Ankit Saxena8Guranda Chitadze9Marcus Lettau10Dieter Kabelitz11Institute of Immunology, University Hospital Schleswig-Holstein, Kiel, GermanyInstitute of Immunology, University Hospital Schleswig-Holstein, Kiel, GermanyInstitute of Immunology, University Hospital Schleswig-Holstein, Kiel, GermanyInstitute of Immunology, University Hospital Schleswig-Holstein, Kiel, GermanyDepartment of Oto-Rhino-Laryngology, University Hospital Schleswig-Holstein, Kiel, GermanyInstitute of Immunology, University Hospital Schleswig-Holstein, Kiel, GermanyInstitute of Immunology, University Hospital Schleswig-Holstein, Kiel, GermanyInstitute of Clinical Molecular Biology, Kiel University, Kiel, GermanyNational Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, United StatesInstitute of Immunology, University Hospital Schleswig-Holstein, Kiel, GermanyInstitute of Immunology, University Hospital Schleswig-Holstein, Kiel, GermanyInstitute of Immunology, University Hospital Schleswig-Holstein, Kiel, GermanyThe functional plasticity and anti-tumor potential of human γδ T cells have been widely studied. However, the epigenetic regulation of γδ T-cell/tumor cell interactions has been poorly investigated. In the present study, we show that treatment with the histone deacetylase inhibitor Valproic acid (VPA) significantly enhanced the expression and/or release of the NKG2D ligands MICA, MICB and ULBP-2, but not ULBP-1 in the pancreatic carcinoma cell line Panc89 and the prostate carcinoma cell line PC-3. Under in vitro tumor co-culture conditions, the expression of full length and the truncated form of the NKG2D receptor in γδ T cells was significantly downregulated. Furthermore, using a newly established flow cytometry-based method to analyze histone acetylation (H3K9ac) in γδ T cells, we showed constitutive H3K9aclow and inducible H3K9achigh expression in Vδ2 T cells. The detailed analysis of H3K9aclow Vδ2 T cells revealed a significant reversion of TEMRA to TEM phenotype during in vitro co-culture with pancreatic ductal adenocarcinoma cells. Our study uncovers novel mechanisms of how epigenetic modifiers modulate γδ T-cell differentiation during interaction with tumor cells. This information is important when considering combination therapy of VPA with the γδ T-cell-based immunotherapy for the treatment of certain types of cancer.https://www.frontiersin.org/article/10.3389/fimmu.2019.00569/fullgamma/delta T cellsHDAC inhibitor(s)histone acetylationNKG2Dmemory T cellstumor microenvironment
spellingShingle Jaydeep Bhat
Samuel Dubin
Alexandra Dananberg
Elgar Susanne Quabius
Elgar Susanne Quabius
Juergen Fritsch
C. Marie Dowds
C. Marie Dowds
Ankit Saxena
Guranda Chitadze
Marcus Lettau
Dieter Kabelitz
Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells
Frontiers in Immunology
gamma/delta T cells
HDAC inhibitor(s)
histone acetylation
NKG2D
memory T cells
tumor microenvironment
title Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells
title_full Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells
title_fullStr Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells
title_full_unstemmed Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells
title_short Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells
title_sort histone deacetylase inhibitor modulates nkg2d receptor expression and memory phenotype of human gamma delta t cells upon interaction with tumor cells
topic gamma/delta T cells
HDAC inhibitor(s)
histone acetylation
NKG2D
memory T cells
tumor microenvironment
url https://www.frontiersin.org/article/10.3389/fimmu.2019.00569/full
work_keys_str_mv AT jaydeepbhat histonedeacetylaseinhibitormodulatesnkg2dreceptorexpressionandmemoryphenotypeofhumangammadeltatcellsuponinteractionwithtumorcells
AT samueldubin histonedeacetylaseinhibitormodulatesnkg2dreceptorexpressionandmemoryphenotypeofhumangammadeltatcellsuponinteractionwithtumorcells
AT alexandradananberg histonedeacetylaseinhibitormodulatesnkg2dreceptorexpressionandmemoryphenotypeofhumangammadeltatcellsuponinteractionwithtumorcells
AT elgarsusannequabius histonedeacetylaseinhibitormodulatesnkg2dreceptorexpressionandmemoryphenotypeofhumangammadeltatcellsuponinteractionwithtumorcells
AT elgarsusannequabius histonedeacetylaseinhibitormodulatesnkg2dreceptorexpressionandmemoryphenotypeofhumangammadeltatcellsuponinteractionwithtumorcells
AT juergenfritsch histonedeacetylaseinhibitormodulatesnkg2dreceptorexpressionandmemoryphenotypeofhumangammadeltatcellsuponinteractionwithtumorcells
AT cmariedowds histonedeacetylaseinhibitormodulatesnkg2dreceptorexpressionandmemoryphenotypeofhumangammadeltatcellsuponinteractionwithtumorcells
AT cmariedowds histonedeacetylaseinhibitormodulatesnkg2dreceptorexpressionandmemoryphenotypeofhumangammadeltatcellsuponinteractionwithtumorcells
AT ankitsaxena histonedeacetylaseinhibitormodulatesnkg2dreceptorexpressionandmemoryphenotypeofhumangammadeltatcellsuponinteractionwithtumorcells
AT gurandachitadze histonedeacetylaseinhibitormodulatesnkg2dreceptorexpressionandmemoryphenotypeofhumangammadeltatcellsuponinteractionwithtumorcells
AT marcuslettau histonedeacetylaseinhibitormodulatesnkg2dreceptorexpressionandmemoryphenotypeofhumangammadeltatcellsuponinteractionwithtumorcells
AT dieterkabelitz histonedeacetylaseinhibitormodulatesnkg2dreceptorexpressionandmemoryphenotypeofhumangammadeltatcellsuponinteractionwithtumorcells